Mechanisms of T-cell Depletion in Tumors and Advances in Clinical Research

Choi Y, Shi Y, Haymaker CL, Naing A, Ciliberto G, Hajjar J. T-cell agonists in cancer immunotherapy. J Immunother Cancer 2020, 8(2).

He J, Xiong X, Yang H, Li D, Liu X, Li S, Liao S, Chen S, Wen X, Yu K, et al. Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response. Cell Res. 2022;32(6):530–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shaw DM, Merien F, Braakhuis A, Dulson D. T-cells and their cytokine production: the anti-inflammatory and immunosuppressive effects of strenuous exercise. Cytokine. 2018;104:136–42.

Article  CAS  PubMed  Google Scholar 

Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR, Ley TJ. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity. 2007;27(4):635–46.

Article  CAS  PubMed  Google Scholar 

Corrado M, Pearce EL. Targeting memory T cell metabolism to improve immunity. J Clin Investig. 2022;132(1).

Pu Y, Ji Q. Tumor-Associated macrophages regulate PD-1/PD-L1 immunosuppression. Front Immunol. 2022;13:874589.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kong F, Wang C, Zhang J, Wang X, Sun B, Xiao X, Zhang H, Song Y, Jia Y. Chinese herbal medicines for prostate cancer therapy: from experimental research to clinical practice. Chin Herb Med. 2023;15(4):485–95.

PubMed  PubMed Central  Google Scholar 

Aoki H, Ueha S, Shichino S, Ogiwara H, Shitara K, Shimomura M, Suzuki T, Nakatsura T, Yamashita M, Kitano S, et al. Transient depletion of CD4(+) cells induces remodeling of the TCR repertoire in gastrointestinal Cancer. Cancer Immunol Res. 2021;9(6):624–36.

Article  CAS  PubMed  Google Scholar 

Kong F, Wang C, Zhao L, Liao D, Wang X, Sun B, Yang P, Jia Y. Traditional Chinese medicines for non-small cell lung cancer: therapies and mechanisms. Chin Herb Med. 2023;15(4):509–15.

PubMed  PubMed Central  Google Scholar 

Lu J, Wu J, Mao L, Xu H, Wang S. Revisiting PD-1/PD-L pathway in T and B cell response: beyond immunosuppression. Cytokine Growth Factor Rev. 2022;67:58–65.

Article  CAS  PubMed  Google Scholar 

Delgoffe GM, Xu C, Mackall CL, Green MR, Gottschalk S, Speiser DE, Zehn D, Beavis PA. The role of exhaustion in CAR T cell therapy. Cancer Cell. 2021;39(7):885–8.

Article  CAS  PubMed  Google Scholar 

Park JA, Wang L, Cheung NV. Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response. J Hematol Oncol. 2021;14(1):142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong PY, Liang SL, Li L, Liu J, Zhang XF. Lotus root polysaccharide inhibits the growth of ovarian cancer cells by blocking the cell cycle. Tradit Med Res. 2023;8(8):44.

Article  Google Scholar 

Hong MMY, Maleki Vareki S. Addressing the Elephant in the immunotherapy room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 therapy. Cancers. 2022;14(6).

Zhang W, Cui N, Ye J, Yang B, Sun Y, Kuang H. Curcumin’s prevention of inflammation-driven early gastric cancer and its molecular mechanism. Chin Herb Med. 2022;14(2):244–53.

CAS  PubMed  PubMed Central  Google Scholar 

Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, Lee W, Yuan J, Wong P, Ho TS, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Sci (New York NY). 2015;348(6230):124–8.

Article  CAS  Google Scholar 

Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014;515(7528):568–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pauken KE, Sammons MA, Odorizzi PM, Manne S, Godec J, Khan O, Drake AM, Chen Z, Sen DR, Kurachi M, et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Volume 354. New York, NY): Science; 2016. pp. 1160–5. 6316.

Google Scholar 

Li Z, Hao E, Cao R, Lin S, Zou L, Huang T, Du Z, Hou X, Deng J. Analysis on internal mechanism of zedoary turmeric in treatment of liver cancer based on pharmacodynamic substances and pharmacodynamic groups. Chin Herb Med. 2022;14(4):479–93.

CAS  PubMed  PubMed Central  Google Scholar 

Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V, Subramaniam S, Blattman JN, Barber DL, Ahmed R. Molecular signature of CD8 + T cell exhaustion during chronic viral infection. Immunity. 2007;27(4):670–84.

Article  CAS  PubMed  Google Scholar 

Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Belk JA, Daniel B, Satpathy AT. Epigenetic regulation of T cell exhaustion. Nat Immunol. 2022;23(6):848–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rao RJ, Yang J, Jiang S, El-Khoury W, Hafeez N, Okawa S, Tai YY, Tang Y, Al Aaraj Y, Sembrat J et al. Post-transcriptional regulation of IFI16 promotes inflammatory endothelial pathophenotypes observed in pulmonary arterial hypertension. bioRxiv: the preprint server for biology. 2024.

Zhang M, Shi Y, Zhang Y, Wang Y, Alotaibi F, Qiu L, Wang H, Peng S, Liu Y, Li Q, et al. miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy. Cancer Immunol Immunotherapy: CII. 2020;69(6):951–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Ham M, Teich R, Philipsen L, Niemz J, Amsberg N, Wissing J, Nimtz M, Gröbe L, Kliche S, Thiel N, et al. TCR signalling network organization at the immunological synapses of murine regulatory T cells. Eur J Immunol. 2017;47(12):2043–58.

Article  PubMed  Google Scholar 

Peng DH, Rodriguez BL, Diao L, Chen L, Wang J, Byers LA, Wei Y, Chapman HA, Yamauchi M, Behrens C, et al. Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8(+) T cell exhaustion. Nat Commun. 2020;11(1):4520.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Solomon I, Amann M, Goubier A, Arce Vargas F, Zervas D, Qing C, Henry JY, Ghorani E, Akarca AU, Marafioti T, et al. CD25-T(reg)-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity. Nat cancer. 2020;1(12):1153–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang G, Feng G, Chen H, Li L, Hu J, Zhou C, Li J, Shen H, Wu F, Tao C, et al. Changes in the TCR repertoire of T-cell subsets during culture of cytokine-induced killer cells. FEBS Lett. 2022;596(20):2696–705.

Article  CAS  PubMed  Google Scholar 

Zhang X, Lao M, Xu J, Duan Y, Yang H, Li M, Ying H, He L, Sun K, Guo C et al. Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors. J Immunother Cancer. 2022;10(3).

Choi H, Cho SY, Schwartz RH, Choi K. Dual effects of Sprouty1 on TCR signaling depending on the differentiation state of the T-cell. Journal of Immunology (Baltimore, Md: 1950). 2006;176(10):6034–6045.

Ai L, Xu A, Xu J. Roles of PD-1/PD-L1 pathway: signaling, Cancer, and Beyond. Advances in experimental medicine and biology. 2020;1248:33–59.

Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X, Shao Q, Zhou B, Zhou H, Wei S, et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells. Cell Rep. 2022;39(12):110986.

Article  CAS  PubMed  Google Scholar 

Celada LJ, Rotsinger JE, Young A, Shaginurova G, Shelton D, Hawkins C, Drake WP. Programmed Death-1 inhibition of phosphatidylinositol 3-Kinase/AKT/Mechanistic target of Rapamycin Signaling impairs sarcoidosis CD4(+) T cell proliferation. Am J Respir Cell Mol Biol. 2017;56(1):74–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li N, Kang Y, Wang L, Huff S, Tang R, Hui H, Agrawal K, Gonzalez GM, Wang Y, Patel SP, et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci USA. 2020;117(33):20159–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yue M, Hu S, Sun H, Tuo B, Jia B, Chen C, Wang W, Liu J, Liu Y, Sun Z, et al. Extracellular vesicles remodel tumor environment for cancer immunotherapy. Mol Cancer. 2023;22(1):203.

Article  CAS  PubMed 

留言 (0)

沒有登入
gif